Cannabinoid Receptor Modulation in Focal Ischemic Stroke: A Systematic Review and Meta-Analysis of Infarct Volume and Behavioral Deficits in Animal Models
Medical Principles and Practice · 2025
DOI: 10.1159/000547277 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medical Principles and Practice, 2025. Verfasst von Hussain Al Dera und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University for Health Science KSAU-HS, Riyadh, Saudi Arabia, derah…. Hauptthemen laut MEDLINE: Ischemic Stroke, Cannabinoid Receptor Agonists, Neuroprotective Agents, Receptors, Cannabinoid. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Objective
This systematic review and meta-analysis aimed to evaluate the impact of cannabinoid (CB) receptor modulation on infarct volume and behavioral deficits in animal models of focal ischemic stroke, with a primary focus on infarct outcomes.
Method
A comprehensive literature search was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, yielding 29 eligible studies for inclusion.
Results
The analysis revealed significant reductions in infarct volume with CB agonists, particularly CB1 and CB2 agonists, indicating their potential as neuroprotective agents. Subgroup analyses further highlighted specific agonists, such as ACEA and KN38-72717, as particularly effective in reducing infarct volume. Additionally, CB antagonists, particularly CB1 antagonists, such as SR141716, showed promising results in reducing infarct volume. Although improvements in neurological scores were observed with both agonists and antagonists, statistical significance was not reached, indicating the need for further investigation.
Conclusion
These results highlight the potential of CB receptor modulation as a neuroprotective strategy in ischemic strokes and underscore the need for further research to elucidate the underlying mechanisms and optimize therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University for Health Science KSAU-HS, Riyadh, Saudi Arabia, derah@ksau-hs.Edu.sa.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia, derah@ksau-hs.Edu.sa.
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, derah@ksau-hs.Edu.sa.
- Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University for Health Science KSAU-HS, Riyadh, Saudi Arabia.
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- Intensive Care Unit, Ministry of the National Guards - Health Affairs, Jeddah, Saudi Arabia.
Zitieren
APA
Dera, H. A., Khojah, A. M., Sakhakhni, A., Alghamdi, S., Alsharef, F., Alqahtani, A., Alamri, F., & Aga, S. S. (2025). Cannabinoid Receptor Modulation in Focal Ischemic Stroke: A Systematic Review and Meta-Analysis of Infarct Volume and Behavioral Deficits in Animal Models. Medical Principles and Practice. https://doi.org/10.1159/000547277
Vancouver
Dera HA, Khojah AM, Sakhakhni A, Alghamdi S, Alsharef F, Alqahtani A, et al. Cannabinoid Receptor Modulation in Focal Ischemic Stroke: A Systematic Review and Meta-Analysis of Infarct Volume and Behavioral Deficits in Animal Models. Medical Principles and Practice. 2025. doi:10.1159/000547277
BibTeX
@article{Dera2025,
author = {Dera, Hussain Al and Khojah, Abdulrahman M and Sakhakhni, Abdulrazak and Alghamdi, Shadell and Alsharef, Fahad and Alqahtani, Abdulaziz and Alamri, Faisal and Aga, Syed Sameer},
title = {Cannabinoid Receptor Modulation in Focal Ischemic Stroke: A Systematic Review and Meta-Analysis of Infarct Volume and Behavioral Deficits in Animal Models},
journal = {Medical Principles and Practice},
year = {2025},
doi = {10.1159/000547277}
}
EUVIMED